CyPath® Lung test supported recommendation for surveillance strategy, rather than subjecting elderly patient to an invasive, risky and costly biopsy procedure Despite a suspicious nodule during a ...

Surgery is a common treatment for non-small cell lung cancer (NSCLC), particularly when the disease is detected early and the tumor is small and is only in one part of the lung. For small cell lung ...

A chest X-ray is often the first test as part of the diagnostic process for non-small cell lung cancer (NSCLC). It can sometimes show a mass, plus its size and location. A chest X-ray cannot diagnose ...

Study by BAMC’s Michael Morris, M.D., and VA’s Sheila Habib, M.D., evaluated potential economic impact of CyPath® Lung for the early detection of lung cancer “Our study suggests the potential for a ...

Patient case study in which CyPath Lung spared a high-risk patient with a suspicious nodule and elevated risk from an ...

For many people with higher risks of developing cancer, the discovery of a nodule in the lung usually means undertaking a diagnostic journey to determine if it’s malignant or benign through invasive ...

In this case study, CyPath® Lung "Unlikely Malignancy" result supported physician’s decision to wait before ordering an invasive lung biopsy In a clinical study, noninvasive CyPath® Lung test ...

Lung wedge resection is surgery that removes a small, wedge-shaped piece of lung tissue. It can treat early stage lung cancer or help doctors diagnose suspicious lumps or shadows on the lungs, visible ...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW) today released a study of a complex clinical case in which CyPath® Lung’s real-time assessment of the lung ...

World Lung Day is an annual campaign observed on September 25th to raise awareness about lung health and promote better lung care around the world. As we age, our lungs, like many other organs, ...

Lung cancer kills more Americans than any other form of cancer: more than prostate cancer and colon cancer combined, and ...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced that unit ...